Introduction
Glioblastoma Multiforme (GM), the highest grade malignant glioma, is a highly malignant brain tumor that is nearly uniformly fatal. GM tumors are generally treated by surgical resection followed by radiation therapy. Radiation therapy is the most eective postoperative adjuvant for GM, however it has not substantially altered long-term disease control (Sheline, 1977) . The median survival of patients with GM has remained approximately 1 year regardless of the therapeutic approach (Ludgate et al., 1988; Prados et al., 1998) . The poor clinical outcome of patients with GM is associated with a characteristic in vivo and in vitro radioresistance of these brain tumors compared to other human neoplasms (Taghian et al., 1992) . We focused on a cell line, SF188, derived from a pediatric patient with glioblastoma multiforme. In contrast to other GM-derived cell lines that exhibit marked resistance to radiation-induced apoptosis, SF188 undergoes extensive apoptosis in response to ionizing radiation (Haas-Kogan et al., 1996b) . In addition, the apoptotic response exhibited by SF188 is p53-independent since SF188 expresses no wild-type (wt) p53 due to a p53 mutation (Chen et al., 1995) .
Chemotherapy and radiation induce apoptosis that, in most cell systems, requires functional wt p53. Although still controversial, such p53-dependent apoptosis likely contributes to the response of many human tumors to anti-neoplastic therapy. However, approximately half of human tumors harbor p53 mutations and would therefore exhibit resistance to p53-dependent apoptosis. We explored the mechanism of p53-independent apoptosis in human GM tumors. Molecular pathways contributing to p53-independent apoptosis have been recently reported (Frenkel et al., 1999; Merritt et al., 1997; Uberti et al., 1999) . Several protein kinases are activated by DNA-damaging agents and may play a key role in p53-independent apoptosis. These include the tyrosine kinase c-Abl, that is activated by DNA-damaging agents (Yuan et al., 1998) , as well as the JNK and ERK MAP kinase cascades that contribute to p53-independent apoptosis in both primary and immortalized cells over-expressing the Ras oncogene (Joneson and Bar-Sagi, 1999) . Similarly, dysregulation of the c-Myc oncogene enhances apoptosis by a p53-independent pathway in several model systems including ®broblasts treated with TNF (Hagiyama et al., 1999; Klefstrom et al., 1997; Trudel et al., 1997) . A better understanding of p53-independent pathways leading to apoptosis holds great promise for improving cancer therapy (DeNardo et al., 1999; Gallagher and Brown, 1999) .
We sought to identify genes required for p53-independent apoptosis by isolating transcripts dierentially expressed in irradiated and unirradiated SF188 glioma cells. We discovered a marked radiationinduced induction of the tumor necrosis factor receptor 1 (TNF-R1)-associated protein, TRADD, in SF188 cells but not in primary human astrocytes, the normal counterparts from which GM tumors arise. TRADD interacts with the death domain of the TNF-R1 receptor and elevated expression of TRADD has been shown to trigger apoptosis (Hsu et al., 1995 (Hsu et al., , 1996 . We demonstrated that ectopically expressed TRADD in SF188 further sensitizes the cells to radiation and chemotherapy-induced apoptosis and that a speci®c inhibitor of TRADD-mediated apoptosis protects SF188 cells from radiation-induced apoptosis.
Results

P53-independent radiation-induced apoptosis requires new protein synthesis
Apoptosis is a process that frequently requires new protein synthesis (Barr and Tomei, 1994; Ferrer, 1992; Ferrer et al., 1995) . Prior to seeking radiation-induced transcripts important for p53-independent apoptosis, we examined whether new protein synthesis is required for radiation-induced apoptosis of SF188 glioma cells. We quantitated the apoptotic response of irradiated SF188 cells in the presence or absence of the protein synthesis inhibitor cycloheximide. Forty-eight hours after exposure to 20 Gy of ionizing radiation, 33.6+4.4% of SF188 cells were apoptotic. Incubation of SF188 cells with cycloheximide for 8 h, beginning immediately prior to irradiation, inhibited the apoptotic response, and resulted in only 4.9+1.8% apoptosis. Cultures that were treated with cycloheximide alone or left untreated showed 2.1+1.0% and 1.8+1.1% apoptosis, respectively (Figure 1) . A time-course of cycloheximide treatment indicated that 8 h was the shortest incubation period that inhibited radiationinduced apoptosis in SF188 cells (data not shown). We therefore chose 8 h after radiation as the time point at which transcripts from irradiated and unirradiated cells were compared by expression arrays.
TRADD transcription is induced by radiation in SF188 cells
Primary, normal human astrocytes and SF188 cells were irradiated in vitro with 20 Gy and 8 h later cDNA was prepared and hybridized to cDNA expression arrays. We sought transcripts whose expression level diered between irradiated and unirradiated SF188 cells, which undergo p53-independent apoptosis, but did not dier between treated and untreated primary astrocytes, which do not undergo apoptosis (Haas- Kogan et al., 1996b) . The cDNA expression array demonstrated several genes that were similarly modulated by radiation in both SF188 and normal astrocytes. In both cell types radiation diminished expression of cyclin A, cyclin B1, p55Cdc and DNA topoisomerase II alpha (Table 1) , all known to decrease in irradiated or growth arrested cells (Datta et al., 1992; Goswami et al., 1996; Guo et al., 2000; Knudsen et al., 1999; Muschel et al., 1991; Villa et al., 1996; Weinstein, 1997; Weinstein et al., 1998) . The cDNA expression array also identi®ed genes that were induced only in primary human astrocytes, expressing wt p53. Radiation treatment of normal astrocytes stimulated expression of several known p53-inducible genes, including p21 Cip1 , Gadd 45 and Bax (Table 1) (el-Deiry, 1998), while minimal or no change in expression of these genes was observed in SF188 cells, harboring a mutant p53 (Table 1) (Chen et al., 1995) . In addition, the cDNA expression array revealed genes Figure 1 Radiation-induced apoptosis in glioma cells is inhibited by cycloheximide. SF188 glioma cell cultures were left untreated (CON), treated with cycloheximide (CHx; 10 mg/ml for 8 h), radiation (RT; 20 Gy), or both cycloheximide and radiation (RT+CHx) and assessed for evidence of DNA strand breaks characteristic of apoptosis (TUNEL method) 48 h later. Shown are the mean and standard deviation of triplicate determinations in a single experiment representative of two independent experiments We con®rmed that TRADD was transcriptionally activated by ionizing radiation, as suggested by the cDNA expression array, using nuclease protection analysis. mRNA isolated from SF188 cells 8 h after mock irradiation or treatment with 20 Gy were hybridized to a radiolabeled TRADD-speci®c cRNA probe. After digestion with RNase, protected fragments were analysed on a polyacrylamide gel and quantitated. As seen in Figure 2 , radiation treatment increased TRADD mRNA levels approximately fourfold relative to the mock irradiated sample without altering mRNA levels of the GAPDH housekeeping gene used as a control.
TRADD protein levels are induced by radiation in SF188 cells
To evaluate whether the radiation-induced increase in TRADD mRNA translated into increased TRADD protein levels, we analysed TRADD expression levels by immunoblotting. In a time-course experiment, TRADD protein levels were unchanged at 8 h, but were increased 5.6-fold at 13 h and remained elevated 15 and 18 h after exposure to 20 Gy (Figure 3a,b) . To assess whether TRADD induction by radiation was speci®c for SF188, the cell line sensitive to radiationinduced apoptosis, we examined primary, normal human astrocytes and additional GM cell lines, all resistant to radiation-induced apoptosis (Haas-Kogan et al., 1996b) . Radiation led to no TRADD induction in primary astrocytes, U87 MG or SF210 and minimal TRADD induction in U251 MG (Figure 3b) .
TRADD overexpression induces apoptosis and activates NF-kB in GM cells
We next asked whether overexpression of high levels of TRADD would kill GM cells in culture. Using transient transfection, we co-expressed b-galactosidase with either TRADD or an empty vector as a control ( Figure 4a ). In both U87 MG and U251 MG cells, coexpression of b-galactosidase with the control vector led to a large fraction of blue-staining cells, re¯ecting the robust transfection eciency of these cell lines. In contrast, after co-expression of b-galactosidase with TRADD, blue-staining cells were nearly absent, indicating TRADD-mediated cytotoxicity (Hsu et al., 1995) . TRADD-induced cytotoxicity was evident when assayed 16, 24 or 48 h after transfection ( Figure 4 and data not shown). Similar results were evident in four independent experiments, as well as in experiments in additional GM cell lines (data not shown). In order to document that TRADD-mediated cell death occurs speci®cally through apoptosis, we used the TUNEL assay to quantitate the apoptotic response of GM cells following TRADD over-expression. In U87 MG and U251 MG, transient transfection of TRADD resulted in 30.2+1.8% and 38.2+11.7% apoptosis, respectively ( Figure 4b ). We sought to document the functional integrity of TRADD expressed by transient transfection in these experiments. Like TNF, TRADD has documented roles in promoting apoptosis and in activating the NF-kB transcription factor complex (Baker and Reddy, 1998) . We therefore assayed NF-kB-dependent luciferase reporter activity in GM cells treated with TNF or transiently transfected with TRADD. We used U251 MG (data not shown) and U87 MG, readily transfectable cell lines, because the low transfection eciency of SF188 precluded their use in this assay. In agreement with published reports, TNF strongly stimulated NF-kB activity in U87 MG and U251 MG. Similarly, ectopic expression of TRADD stimulated NF-kB activity, although to a lesser degree than TNF. Since ectopic expression of TRADD kills GM cells directly, we suspected that our ability to measure NF-kB-activation may be compromised by loss of cells due to TRADD-induced apoptosis (Hsu et al., 1995) . We predicted that blocking apoptosis would lead to an increase in measurable luciferase activity in cells transfected with TRADD (Hsu et al., 1995) . To test this we assayed NF-kB-dependent luciferase reporter activity stimulated by TNF or TRADD, in the presence or absence of crmA (cytokine response modi®er enzyme A), an interleukin-1-converting enzyme (ICE)-speci®c protease inhibitor, known to block cell death but not NF-kB activation. As predicted, crmA expression augmented the observed TRADDinduced NF-kB activation (Figure 4c ). TNF-induced NF-kB stimulation was unchanged by crmA ( Figure  4c ) because TNF requires cycloheximide to trigger apoptosis (Itoh and Nagata, 1993 ; and data not shown).
Exogenous TRADD expression sensitizes GM cells to ionizing radiation and chemotherapy
We sought to establish a causal role for radiationinduced TRADD expression in the unique radiosensitivity of SF188 as well as assess whether ectopic TRADD expression would sensitize additional GM cell lines to radiation and chemotherapy. To this end we generated pools of SF188 cells and U251 MG cells Floating and adherent cells were pooled 8 h (for U87 MG) or 24 h (for U251 MG) after transfection and subjected to the TUNEL assay for apoptotic cells. Error bars represent the standard deviation for at least two independent experiments. (c) Expression vectors encoding the indicated protein were cotransfected into U87 cells together with NF-kB-luciferase and pRL-TK reporter plasmids. Designated cultures were stimulated with TNF for 8 h. NF-kB activity is presented relative to Renilla luciferase activity that is constitutively expressed by pRL-TK and is used to control for dierences in transfection eciency. Three independent transfections were performed for each measurement expressing exogenous TRADD. Although TRADD was cytotoxic in both cell lines when transiently expressed at high levels ( Figure 4 and data not shown), we were able to isolate pools stably expressing exogenous TRADD. After exposure to 5 Gy of ionizing radiation, SF188-TRADD and U251-TRADD exhibited enhanced sensitivity to radiation-induced cell death compared with SF188-pLXSN and U251-pLSXN control pools expressing the empty vector ( Figure 5) .
In addition to radiation sensitivity in the isogenic SF 188 clones diering only in TRADD expression, we assessed susceptibility to chemotherapy-induced cell death. Two days after exposure to the chemotherapeutic agents cisplatin, 5-¯uorouracil, and BCNU we quantitated cell death as measured by Trypan blue exclusion (data not shown). SF188-TRADD exhibited enhanced sensitivity compared with SF188-pLXSN. Cisplatin (1 mM), 5-¯uorouracil (5 mg/ml) and BCNU (100 mM) each induced 47.0+1.4%, 38.0+2.1% and 82.5+3.5% cell death, respectively in SF188-TRADD, whereas only 20.0+5.7%, 17.0+4.4% and 53.0+4.2% cell death were seen in SF188-pLXSN. Expression of the exogenous TRADD was documented in SF188-TRADD and U251-TRADD by immunoblot analysis using an anti-TRADD antibody ( Figure 5 ).
Expression of dominant negative FADD increases cellular resistance to radiation-induced apoptosis
To further corroborate the role of radiation-induced TRADD expression in GM radiosensitivity, we generated pools of SF188 cells stably expressing a dominant-negative mutant of FADD (FADD-DN) (Chinnaiyan et al., 1996; Hsu et al., 1996) . This Nterminal truncation mutant of FADD (residues 80 ± 205) has been shown to inhibit TNF-and TRADDinduced cell death (Chinnaiyan et al., 1996; Hsu et al., 1996) . SF188 pools were generated by transfection of either FADD-DN (SF188-FADD-DN) or the pBabe Hygro empty vector as a control (SF188-pBabe). A time-course of cell death following exposure to 20 Gy revealed that FADD-DN expression enhanced cellular resistance to radiation-induced cell death (Figure 6a ). To document that FADD-DN speci®cally protected SF188 cells from radiation-induced apoptosis, we used the TUNEL assay to quantitate cells with fragmented DNA characteristic of apoptosis. Whereas 20 Gy induced apoptosis in 31.7+4.1% of SF188-pBabe pools, only 17.3+2.4% of SF188-FADD-DN pools were apoptotic, indicating that a FADD-dependent pathway contributes to radiation-induced apoptosis in SF188 cells (Figure 6b) .
Although controversy exists, susceptibility to apoptosis likely contributes to overall cellular radiation resistance, as measured by clonogenic survival assays. Traditionally, radiation resistance has been assayed by such clonogenic survival curves (Brown and Wouters, 1999) and we therefore asked whether transcriptional up-regulation of TRADD, which mediates enhanced radiation-induced apoptosis, will also be associated with increased clonogenic resistance to radiation. To test this hypothesis we used FADD-DN to block TRADD-mediated apoptosis in the two most sensitive GM cell lines, each of which exhibited transcriptional up-regulation of TRADD following radiation exposure (Figure 3b ). We performed clonogenic survival assays on pools of U251 MG and SF 188 cells stably expressing either FADD-DN (SF188-FADD-DN and U251-FADD-DN) or the pBabe Hygro empty vector as a control (SF188-pBabe and U251-pBabe). Expression of FADD-DN lead to increased clonogenic resistance to radiation in both U251 MG (Figure 6c ) and SF 188 cells (data not shown).
Discussion
In this study we used broad-scale gene expression analysis to explore the mechanism of p53-independent apoptosis induced by ionizing radiation. In primary human astrocytes, the normal cellular counterparts from which malignant gliomas arise, radiation induces a growth arrest rather than apoptosis (Haas-Kogan et al., 1996b) . Expression array analysis con®rmed the induction of genes, such as p21 Cip1 and Gadd 45, known to increase after radiation and mediate a cell cycle arrest (el-Deiry, 1998). P53 regulates the radiation-induced expression of p21 Cip1 , Gadd 45 and Bax (el-Deiry, 1998). As expected, expression of p21 Cip1 , Gadd 45 and Bax was induced by radiation only in primary human astrocytes expressing wt p53 with minimal or no change in expression of these genes in SF188 cells, harboring a mutant p53 (Chen et al., 1995) . The modest 1.5-fold induction of p21 Cip1 expression in SF188 cells is likely due to previously (Akashi et al., 1995) .
In contrast to primary human astrocytes, SF188 malignant glioma cells do not arrest in G1 in response to radiation, but rather undergo p53-independent apoptosis (Haas- Kogan et al., 1996a,b) . Expression array analysis of SF188 cells revealed that ionizing radiation induced TRADD expression to a greater extent than any other examined gene. TRADD was transcriptionally activated in SF188, a cell line uniquely susceptible to radiation-induced apoptosis, but not in radioresistant cell lines or primary human astrocytes.
TRADD is a component of the apoptotic pathway initiated by the TNF superfamily of death receptors (Baker and Reddy, 1998) . These receptors, like other receptors that are devoid of catalytic activity, utilize cellular proteins to execute a cascade culminating in cell death (Baker and Reddy, 1998; Tartaglia et al., 1993) . After ligand-induced trimerization of the tumor necrosis factor receptor-1 (TNF-R1), TRADD functions as an adaptor protein, a process mediated by a Cterminal 111 amino acid TRADD death domain. TNF-R1-TRADD then executes the apoptotic pathway after FADD couples this complex to activation of Caspase-8 (Baker and Reddy, 1998) . We found that blocking the TRADD-mediated pathway using FADD-DN inhibited radiation-induced apoptosis of SF188 cells. Conversely, stable expression of exogenous TRADD enhanced radiation-induced apoptosis of GM cell lines, re¯ecting the biological signi®cance of TRADD regulation in p53-independent apoptosis.
Regulation of apoptosis by the TNF superfamily of death receptors is dominated by protein ± protein interactions and evidence for transcriptional regulation of components of these pathways is limited. Exceptions include components of the CD95 system, whose transcriptional up-regulation may mediate apoptosis induced by anti-neoplasic therapy (BaÈ umler et al., 1996; Friesen et al., 1996; Fulda et al., 1997; Kolbus et al., 2000; MuÈ ller et al., 1997; Owen-Schaub et al., 1995) . Chemotherapy-induced apoptosis of hepatoma cells has been shown to be FADD-DN, closed circles) . The number of colonies arising after the speci®ed doses of X-rays was assessed 2 weeks after radiation treatment. Where error bars are not evident, they are smaller than the size of the symbol representing the data point. Similar results were obtained in two independent experiments mediated, in part, by p53-dependent stimulation of the CD95 receptor/ligand system (MuÈ ller et al., 1997) . Similarly, up-regulation of CD95L mediates druginduced apoptosis in leukemia cell lines (Friesen et al., 1996) and wt p53 has been shown to induce CD95 transcription in several human tumor cell lines (Friesen et al., 1996; Herr et al., 1997; MuÈ ller et al., 1997) . In addition to CD95, wt p53 stimulates transcription of TRAIL-R2 (DR-5, TRICK2, Killer), a newly isolated member of the TNFR family (Wu et al., 1997) . TRAIL-R2 is a death domain containing-receptor for TRAIL (TNF-related apoptosis-inducing ligand) and is induced by DNA-damaging agents in a p53-dependent fashion (Wu et al., 1997) .
Our study is the ®rst to demonstrate that transcriptional regulation of TRADD can mediate susceptibility to apoptosis. Radiation treatment led to increased TRADD protein expression by inducing TRADD transcription in a p53-independent fashion, thereby contributing to radiation-induced apoptosis of GM cells. Induction of TRADD expression by radiation was statistically signi®cant only in SF188, the cell line uniquely sensitive to p53-independent apoptosis. However, radiation-induced TRADD expression was also observed, albeit to a lesser degree, in U251 MG. Interestingly, U251 MG is second only to SF188 in its radiosensitivity (Haas-Kogan et al., 1996a) , and stable expression of exogenous TRADD in SF188 and U251 MG increased their sensitivity to radiation-induced apoptosis. Although our results demonstrate a role for transcriptional-regulation of TRADD in the radiation response of relatively radiosensitive GM cell lines the signi®cance of our ®ndings is limited by our inability to extend our ®ndings to a large number of GM cell lines. We are currently examining whether TRADD is transcriptionally regulated by radiation in various additional tumor types.
Expression of high levels of TRADD by transient transfection of GM cell lines led to apoptosis, a ®nding consistent with published reports in which TRADD overexpression induced apoptosis of several human cell lines (Hsu et al., 1995 (Hsu et al., , 1996 . Our ability to generate transfected pools that stably expressed TRADD was somewhat unexpected. At least two likely explanations for this observation exist: low TRADD expression levels may lead to enhanced susceptibility to apoptosis whereas high expression levels, as seen in the transient transfection, directly induce apoptosis. Alternatively, generating pools stably expressing TRADD may select for cells that are less susceptible to TRADD-induced apoptosis and undergo apoptosis only after the added insult of irradiation.
Our ®ndings generate interest in utilizing TRADD in gene therapy for GM tumors, particularly in light of its dual function of directly inducing rapid apoptosis and sensitizing GM cells to standard anti-neoplastic therapy. The poor clinical outcome of patients with GM tumors is associated with marked resistance to apoptosis (Haas-Kogan et al., 1996a,b) . P53-independent apoptosis induced in GM cells by ionizing radiation and chemotherapy requires high doses and long incubation periods (Haas-Kogan et al., 1996a,b) . In contrast, TRADD induced extensive apoptosis within the ®rst few hours after expression of exogenous TRADD. Furthermore, our data suggest that cells not directly killed by TRADD may exhibit enhanced sensitivity to radiation, the standard adjuvant treatment for GM tumors. Cancer therapy requires a therapeutic index by which tumor cells are killed more readily than normal tissues. We are currently exploring whether TRADD over-expression induces apoptosis in normal astrocytes and neurons residing in the brain. Recent excitement has been generated by the ®nding that TRAIL may selectively kill tumor cells while sparing normal cells (Gura, 1997; Pan et al., 1997a,b; Pitti et al., 1996; Sheridan et al., 1997; Wiley et al., 1995) . A cytokine with selective tumor cytotoxicity would clearly oer the most promising therapeutic potential. Unfortunately, astrocytes, the normal cellular counterparts from which GM tumors arise, were exquisitely susceptible to TRAIL-induced apoptosis in vitro (French and Tschopp, 1999; Walczak et al., 1999) . Thus, TRAIL may not provide a therapeutic index in the treatment of GM tumors. Alternative strategies we are pursuing to enhance the therapeutic index in the treatment of GM tumors include local gene delivery directly into the tumor bed and the use of a radiationinducible promoter to drive TRADD expression.
Materials and methods
Cell culture and irradiation
Cell lines were maintained as exponentially growing monolayer cultures in Dulbecco's modi®ed Eagle's media (DMEM) supplemented with 10% fetal bovine serum (GIBCO ± BRL), penicillin, and streptomycin in a humidi®ed incubator at 378C and 8% CO 2 . Normal human astrocytes were isolated from second trimester elective abortion fetal brain by established methods (Murphy, 1990) and were con®rmed to be astrocytic by uniform staining (data not shown) with an anti-glial ®brillary acid protein (GFAP) antibody (Boehringer ± Mannheim). Primary cultures were grown in a DME H-21-based medium with 10 ng/ml EGF, 10 nM hydrocortisone, 10 ng/ml biotin, insulin/transferrin/selenium supplement, biotin 10 ng/ml (all from Sigma) and 15 mg/ml of bovine pituitary extract (Clonetics). The above medium was mixed with DME/10% fetal calf serum at a 10 : 2 ratio.
Irradiation of cultures was performed as indicated at room temperature in a 150 kV Philips X-ray machine, without a ®lter, at a dose rate of 2.4 Gy/min. For drug treatment, cells were exposed to 10 mg/mL cycloheximide for the designated time periods.
Nucleic acid array analysis
Total RNA was isolated from samples by the GITC extraction method (Atlas Pure RNA isolation kit, Clontech), with 20 mg/ml glycogen added as a carrier to aid precipitation. RNA from two samples was converted into 32 P-labeled ®rst-strand cDNA using the sequence speci®c primers provided with the Atlas arrays (Clontech) and puri®ed from unincorporated 32 P-labeled nucleotides and small cDNA fragments on a Quick Spin Column, Sephadex G-25 (Boehringer ± Mannheim). Pooled fractions showing the highest incorporation of label were denatured, neutralized, and hybridized separately with cDNA array membranes overnight in a roller bottle at 688C. After a series of washes, the membranes were exposed to phosphorimaging screens for quanti®cation using a STORM phosphoimager (Molecular Dynamics).
Plasmids
The TRADD-plxsn plasmid was generated by digesting a pRK-TRADD plasmid (obtained from DV Geoddel) with EcoRI and ligating the Myc-tagged TRADD insert into the pLXSN retroviral vector similarly digested with EcoRI (Hsu et al., 1995) . The insert was con®rmed by sequencing. Retroviral stocks expressing TRADD were prepared using amphotropic phoenix cells transfected with pLXSN-TRADD using lipofectamine transfection reagent. Viral supernatant was harvested 48 h after transfection. Stable cell lines expressing TRADD or control vector were generated by infection with pLXSN-TRADD or pLXSN encoding retrovirus over 24 h. Viral supernatant was then removed and selection with 500 mg/ml of G418 (Genticin, GIBCO) was initiated 24 h later. Retroviral constructs encoding FADD-DN (Chinnaiyan et al., 1996) were generated by digesting a pcDNA3-FADD-DN plasmid (obtained from VM Dixit) with XhoI/KpnI and ligating the AU1-tagged FADD-DN insert into a similarly digested pBabeHygro retroviral vector (obtained from P RodriguezViciana). The insert was con®rmed by sequencing. Retroviral stocks expressing FADD-DN were prepared as described above. Stable cell lines expressing FADD-DN were generated by drug selection with 200 mg/ml Hygromycin (Calbiochem).
Luciferase reporter activity
U87 and U251 cells (0.8610 5 and 0.5610 5 cells/well respectively) were seeded into 12-well plates, and transfected the following day using the Fugene-6 transfection reagent (Roche). In addition to the speci®ed experimental plasmids (0.17 mg/plasmid/well), all cells were transfected with a luciferase reporter driven by the NF-kB consensus site from the human immunode®ciency virus long terminal repeat (HIV LTR; 0.17 mg/well) (Kane et al., 1999) . All transfections included the pRL-TK plasmid (9 ng/well, Promega) allowing Renilla luciferase activity to be used as an internal control for dierences in transfection eciency. Eighteen hours after transfection, selected cultures were treated with TNF (20 ng/ ml) for 6 h. Luciferase activity was measured 24 h after transfection using the Dual-Luciferase reporter assay system (Promega) and a Microplate luminometer LB96V (EG and G Berthold).
Analysis of cell death
Cell viability was quantitated by Trypan blue exclusion. One hundred thousand cells were seeded in each well of a six-well plate 24 h prior to experimental treatment. At speci®ed times after treatment, adherent cells were harvested by trypsinization, pooled with non-adherent, stained with Trypan blue and counted on a hemocytometer.
Cell death after transient transfection was quantitated by co-transfection of b-galactosidase with the speci®ed test vector, as previously described (Kumar et al., 1994) . Stained cells were detected microscopically and the number of total cells and blue cells was quantitated.
Apoptotic cells were identi®ed and quanti®ed using the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method. At speci®ed times after treatment, cells were collected by trypsinization, pooled with non-adherent cells, washed with PBS and ®xed for 30 min in 2% paraformaldehyde in PBS. The cells were then washed in PBS, resuspended in 70% ethanol at 48C for 1 h and cytospun onto Superfrost slides (Fisher). Air dried samples were then labeled with digoxigenin-conjugated deoxyuridine triphosphate (dUTP) using terminal deoxynucleotide transferase according to the distrubutor's instructions (Oncor, Gaithersburg, MD, USA).
Immunoblot (Western blot)
TRADD expression in MG cells was determined by immunoblotting of whole cell lysates using a TRADDspeci®c monoclonal antibody (Transduction Laboratories, clone 37). Anti-b-actin antibody was obtained from Amersham and anti-FADD antibody was obtained from Transduction Laboratories (monoclonal antibody, clone 1).
Whole-cell lysates were denatured by boiling in SDS and 2-mercaptoethanol. Equal amounts of protein extracts (20 mg) were subjected to 12% polyacrylamide gel electrophoresis in denaturing conditions. Fractionated proteins were transferred onto polyvinylidene di¯uoride membranes and the eciency of transfer was assessed by Ponceau S. staining of the membranes. The antigen-antibody complex was visualized by enhanced chemiluminescence method (ECL, Amersham) using horseradish peroxidase-coupled secondary antibodies. A photo-densitometer (Alpha Innotech) was used to quantitate expression levels.
Ribonuclease protection assay
For quanti®cation of mRNA expression levels a human TRADD speci®c cDNA probe was generated by PCR using oligonucleotides TRADD1 (5'-TGGAGAACCTGGATG-GCCTTAGGGTT-3') and TRADD2 (5'-CAGGACAC-CAAAGATCAAGGTGCTTCAT-3') and cloned into the pTOPOII vector (Invitrogen). To generate radiolabeled antisense cRNA probes, the plasmid was linearized with BamHI and in vitro transcribed using 32 P-dCTP and SP6 RNA polymerase. Ribonuclease protection assay was performed with the RPA II kit (Ambion). Two hundred and ®fty ng of mRNA were used in each reaction. Subsequent to RNase treatment, protected fragments were analysed on a 6% denaturing polyacrylamide gel. The gel was dried and exposed to Kodak AR X-Omat ®lm. To con®rm equal RNA loading a probe speci®c for the housekeeping gene GAPDH was added to each reaction.
Clonogenic radiation sensitivity assays
Cells were grown and irradiated as described above. On the day prior to irradiation, autologous cells were irradiated with 40 Gy and plated in six-well plates to function as a feeder layer. On the following day, cells for the clonogenic survival curve were seeded as previously described (Sarkar et al., 1993) . In brief, after exposure to a speci®ed dose of radiation, cultures were trypsinized, counted and plated at speci®ed concentrations in the wells already containing an autologous feeder layer. These cultures were then incubated for 21 days and colonies of 450 cells were scored. Cell survival measurements were ®tted to a linear quadratic mathematical model using the FIT 2.5 program (Albright, 1987; Fertil and Malaise, 1985) . Within each of at least two independent experiments, two to four dierent dilutions were made per radiation dose and each dilution was plated in multiples of six.
